Effect of Platelet-rich Fibrin on Rotator Cuff Repair (PRP-Fibrin)
Primary Purpose
Rotator Cuff Tears of the Shoulder
Status
Completed
Phase
Phase 2
Locations
Spain
Study Type
Interventional
Intervention
Arthroscopic repair without platelet rich fibrin
PRF (vivostat ®) administration after rotator cuff repair
Sponsored by
About this trial
This is an interventional treatment trial for Rotator Cuff Tears of the Shoulder focused on measuring rotator cuff, shoulder, platelet rich plasma, fibrin
Eligibility Criteria
Inclusion Criteria:
- Massive rotator cuff tears affecting supraspinatus and infraspinatus
- Failed conservative treatment for at least 6 months
- No hematologic disorder
Exclusion Criteria:
- Rotator cuff affecting subscapularis
- chronic infectious disease
- anemia
- clot disorders
- low platelet count
- history of difficulty in venous puncture
Sites / Locations
- Hospital Universitario La Paz
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
PRF
Control
Arm Description
the group in which the PRF was administered
repair without PRF
Outcomes
Primary Outcome Measures
rotator cuff tear healing rate after surgical reconstruction evaluated by arthro-MRI
Secondary Outcome Measures
functional outcome evaluated with constant score
disability outcome evaluated with dash score
Full Information
NCT ID
NCT01612845
First Posted
June 4, 2012
Last Updated
June 5, 2012
Sponsor
Hospital Universitario La Paz
Collaborators
spanish society of orthopedics and traumatology
1. Study Identification
Unique Protocol Identification Number
NCT01612845
Brief Title
Effect of Platelet-rich Fibrin on Rotator Cuff Repair
Acronym
PRP-Fibrin
Official Title
Platelet-Rich Fibrin for Arthroscopically Repaired Massive Rotator Cuff Tears: A Prospective Randomized Pilot Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2012
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
May 2009 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Universitario La Paz
Collaborators
spanish society of orthopedics and traumatology
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study was to prospectively evaluate the influence of local application of Platelet Rich Fibrin (PRF) on the functional outcome and integrity of the arthroscopically repaired tendons in patients with massive tears of the rotator cuff.
Detailed Description
A prospective, randomized clinical trial was performed on 28 patients (22 females, 6 males) with an average age of 65 years (range, 53 to 77) undergoing complete arthroscopic repair of a massive rotator cuff tear. In 14 patients, after the repair was completed, 6 cc. of PRF (vivostat ®) were locally applied to the repair site. In 14 patients no addition of PRF was performed. All patients underwent an arthro-MRI to evaluate the integrity of the repair and a clinical exam one year after the operation. All patients were then followed clinically at a minimum of 2 years. Functional outcome was evaluated with the Constant and DASH scores.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rotator Cuff Tears of the Shoulder
Keywords
rotator cuff, shoulder, platelet rich plasma, fibrin
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
28 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PRF
Arm Type
Experimental
Arm Description
the group in which the PRF was administered
Arm Title
Control
Arm Type
Active Comparator
Arm Description
repair without PRF
Intervention Type
Procedure
Intervention Name(s)
Arthroscopic repair without platelet rich fibrin
Intervention Description
after the tendon is repaired, no additional procedures are performed and no PRF is administered
Intervention Type
Biological
Intervention Name(s)
PRF (vivostat ®) administration after rotator cuff repair
Intervention Description
7cc. of autologous PRF are locally administered to the repair site after reconstruction of the rotator cuff
Primary Outcome Measure Information:
Title
rotator cuff tear healing rate after surgical reconstruction evaluated by arthro-MRI
Time Frame
one year
Secondary Outcome Measure Information:
Title
functional outcome evaluated with constant score
Time Frame
two years
Title
disability outcome evaluated with dash score
Time Frame
two years
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Massive rotator cuff tears affecting supraspinatus and infraspinatus
Failed conservative treatment for at least 6 months
No hematologic disorder
Exclusion Criteria:
Rotator cuff affecting subscapularis
chronic infectious disease
anemia
clot disorders
low platelet count
history of difficulty in venous puncture
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Samuel A Antuña, MD PhD
Organizational Affiliation
H. La PAz
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Raul Barco, MD PhD
Organizational Affiliation
HU La PAz
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jose M Martinez, MD
Organizational Affiliation
HU La Paz
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jose M sanchez, MD
Organizational Affiliation
HU La Paz
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario La Paz
City
Madrid
ZIP/Postal Code
28046
Country
Spain
12. IPD Sharing Statement
Citations:
PubMed Identifier
21737832
Citation
Jo CH, Kim JE, Yoon KS, Lee JH, Kang SB, Lee JH, Han HS, Rhee SH, Shin S. Does platelet-rich plasma accelerate recovery after rotator cuff repair? A prospective cohort study. Am J Sports Med. 2011 Oct;39(10):2082-90. doi: 10.1177/0363546511413454. Epub 2011 Jul 7.
Results Reference
background
PubMed Identifier
21570659
Citation
Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg. 2011 Jun;20(4):518-28. doi: 10.1016/j.jse.2011.02.008.
Results Reference
background
PubMed Identifier
21160018
Citation
Castricini R, Longo UG, De Benedetto M, Panfoli N, Pirani P, Zini R, Maffulli N, Denaro V. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med. 2011 Feb;39(2):258-65. doi: 10.1177/0363546510390780. Epub 2010 Dec 15.
Results Reference
background
PubMed Identifier
21802625
Citation
Barber FA, Hrnack SA, Snyder SJ, Hapa O. Rotator cuff repair healing influenced by platelet-rich plasma construct augmentation. Arthroscopy. 2011 Aug;27(8):1029-35. doi: 10.1016/j.arthro.2011.06.010.
Results Reference
result
Learn more about this trial
Effect of Platelet-rich Fibrin on Rotator Cuff Repair
We'll reach out to this number within 24 hrs